Program Affiliation Cont... OPTIMIZE - Zim
Date
Title
Status
All
Completed
Current
Program Affiliation
All
HPTN
MTCT-Plus
COVID
MCAP
UTAP
Global TA
PHIA
QICIP
TRACE
CQUIN
GNCBP
OpCon
OPTIMIZE
Project Location
All
Mozambique
Angola
Burundi
Liberia
Philippines
Brazil
Guatemala
Georgia
Haiti
China
Cameroon
Côte d’Ivoire
Democratic Republic of the Congo
Lesotho
Kazakhstan
Kyrgyzstan
Kenya
Namibia
Ethiopia
Nigeria
Rwanda
Tajikistan
Malawi
Sierra Leone
Zimbabwe
Tanzania
Eswatini
South Sudan
Mali
South Africa
Uganda
Zambia
United States
Ukraine
Myanmar
Central Asia
september
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
Find out more at https://icap.columbia.edu/where-we-work/optimize/
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
october
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
Find out more at https://icap.columbia.edu/where-we-work/optimize/
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
november
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
Find out more at https://icap.columbia.edu/where-we-work/optimize/
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
december
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
Find out more at https://icap.columbia.edu/where-we-work/optimize/
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
january
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,
Project Details
Find out more at https://icap.columbia.edu/where-we-work/optimize/
Accelerating Availability of Optimal Antiretroviral Drugs (OPTIMIZE)
Project Details
The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries,